Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05694793 · ClinicalTrials.gov registry record · NA
Trial for Reliability of Urodynamics SysTem
A NA study of Urologic Diseases and Urodynamics, sponsored by Bright Uro.
- Recruiting
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 4
- Study locations
NCT05694793: Recruiting NA study of Urologic Diseases and Urodynamics, sponsored by Bright Uro.
NCT05694793 is a NA study of Urologic Diseases and Urodynamics that is actively recruiting participants, run by Bright Uro. The registered enrollment target is 28 participants, below the 118-participant average among 11 other Urologic Diseases trials with a reported enrollment target (76% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05694793, a NA study of Urologic Diseases and Urodynamics, is actively recruiting participants, sponsored by Bright Uro.
- RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this prospective trial is to assess the safety and reliability of the Glean Urodynamics System (GUS) in adult females with lower urinary tract symptoms. The main question\[s\] it aims to answer are: • What is GUS's ability to safely and reliably conduct wireless, catheter-free monitoring of vesical pressure compared to the vesical pressures collected with conventional urodynamics? Participants will undergo a conventional urodynamics exam, a simultaneous urodynamics exam with GUS, ambulatory urodynamics with GUS, and extended home monitoring with GUS. Researchers will compare GUS data with that from a conventional urodynamics exam.
Primary Outcome
Proportion of participants experiencing a qualifying adverse event attributable to the investigational device
Conditions Studied
Interventions
- DEVICE Glean Urodynamics System
Study Locations (4)
California
- Tri Valley Urology Medical Group - Murrieta
- University of California San Diego - San Diego
- Unio Health Partners - Torrence
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2025-06-03 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT05694793 shows while recruiting
NCT05694793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 118-participant average among 11 other Urologic Diseases trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Urologic Diseases appearing as the primary indexed condition, and to 1 intervention - of which Glean Urodynamics System is the first listed.
NCT05694793 reports a single indexed study location in California, Ohio.
Frequently Asked Questions
What is clinical trial NCT05694793 about?
NCT05694793 is a clinical study titled "Trial for Reliability of Urodynamics SysTem". The goal of this prospective trial is to assess the safety and reliability of the Glean Urodynamics System (GUS) in adult females with lower urinary tract symptoms. The main question\[s\] it aims to answer are: • What is GUS's ability to safely and reliably conduct wireless, catheter-free monitorin...
What is the current status of trial NCT05694793?
This trial is currently recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2025-06-03. Estimated completion is 2026-07.
What conditions does trial NCT05694793 study?
This clinical trial studies the following conditions: Urologic Diseases, Urodynamics.
What interventions are being tested in trial NCT05694793?
The interventions under investigation include: Glean Urodynamics System (DEVICE).
Who is sponsoring clinical trial NCT05694793?
This trial is sponsored by Bright Uro, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05694793 being conducted?
This trial has 4 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urologic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05694793's enrollment target sits among peer trials
28 9th of 11 higher than 3 of 11 other Urologic Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urologic Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
RECRUITING · NA
-
Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures
RECRUITING · NA
-
INTIBIA Pivotal Study
ACTIVE NOT RECRUITING · NA
-
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
COMPLETED · NA
-
Percutaneous Externally-Assembled Laparoscopic Urologic Surgery
COMPLETED · NA
-
Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI